AVR 0.00% $18.00 anteris technologies ltd

Closing price manipulation?, page-27

  1. 26,807 Posts.
    lightbulb Created with Sketch. 1737
    I meant ADAPT, from 2018 quarterly and still haven't received TGA approval.

    "Emerging Markets performed well but growth was hindered by delayed Therapeutic Goods Administration (TGA) approval to launch ADAPT® in Australia which was anticipated during this quarter. This delay directly impacts revenue for Australia but also inhibits entry into other emerging markets such as Thailand, Taiwan, Vietnam and the Philippines, who favour applications with home market approval. Admedus has complied with all aspects of the stringent TGA process and remains confident of securing approval in the second half of this year."
    Last edited by AlCp: 11/05/20
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.